Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/12/2021 10/13/2021 10/14/2021 10/15/2021 10/18/2021 Date
19.25(c) 19.94(c) 19.59(c) 19.71(c) 19.62 Last
12 640 24 421 12 903 20 311 694 Volume
-2.23% +3.58% -1.76% +0.61% -0.46% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4,44 M - -
Net income 2021 -33,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -29,0x
Yield 2021 -
Sales 2022 0,50 M - -
Net income 2022 -47,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -19,0x
Yield 2022 -
Capitalization 389 M 389 M -
Capi. / Sales 2021 87,5x
Capi. / Sales 2022 777x
Nbr of Employees 78
Free-Float 15,8%
More Financials
Company
Rani Therapeutics Holdings, Inc is a clinical stage biotherapeutics company. The Company’s technologies enable the development of orally administered biologics. It develops the RaniPill capsule, which replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill that is designed to administer a precise therapeutic dose of medication upon deployment in the... 
More about the company
All news about RANI THERAPEUTICS HOLDINGS, INC.
09/29RANI THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
09/23Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
GL
09/20RANI THERAPEUTICS HOLDINGS, INC.(NAS : RANI) added to S&P TMI Index
CI
09/13RANI THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
09/13RANI THERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition, Financia..
AQ
09/13RANI THERAPEUTICS : Reports Second Quarter 2021 Financial Results, Provides Corporate Upda..
AQ
09/13Rani Therapeutics Holdings, Inc. Announces Unaudited Consolidated Earnings Results for ..
CI
09/13Rani Therapeutics Holdings, Inc. Appoints Talat Imran as Chief Executive Officer
CI
09/13Rani Therapeutics Holdings, Inc. Announces Executive Appointments
CI
09/09RANI THERAPEUTICS : Announces Appointment of Eric Groen as General Counsel
AQ
08/25RANI THERAPEUTICS : Canaccord Genuity Starts Rani Therapeutics Holdings at Buy With $29 Pr..
MT
08/25RANI THERAPEUTICS : BTIG Starts Rani Therapeutics Holdings at Buy With $24 Price Target
MT
08/24RANI THERAPEUTICS : Cantor Fitzgerald Starts Rani Therapeutics Holdings at Overweight with..
MT
08/24RANI THERAPEUTICS : Stifel Starts Rani Therapeutics Holdings at Buy with $24 Price Target
MT
08/24RANI THERAPEUTICS : BofA Securities Starts Rani Therapeutics Holdings at Buy with $23 Pric..
MT
More news
News in other languages on RANI THERAPEUTICS HOLDINGS, INC.

- No features available -

More news
Analyst Recommendations on RANI THERAPEUTICS HOLDINGS, INC.
More recommendations
Chart RANI THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Rani Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RANI THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 19,71 $
Average target price 24,60 $
Spread / Average Target 24,8%
EPS Revisions
Managers and Directors
Talat Imran Chief Executive Officer & Director
Svai S. Sanford Chief Financial Officer
Mir A. Imran Executive Chairman
Mir Hashim Chief Scientific Officer
Dennis Arthur Ausiello Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RANI THERAPEUTICS HOLDINGS, INC.0.00%389
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414